PER
Click for more information
2.35% 8.7¢ percheron therapeutics limited

"The Company believes that interim data could help direct future...

  1. edsel
    159 Posts.
    lightbulb Created with Sketch. 3
    clock Created with Sketch.
    02/08/13
    11:14
    Post #: 12146318
    "The Company believes that interim data could help direct future development plans beyond Phase II and bring forward
    discussions with prospective partners on ATL1103 ahead of the final trial results."

    Remember Teva
    Their gonna sell another kidney,
    ANP Price at posting: 16.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TLG Talga to form joint venture with lithium producer SQM to develop Sweden's Aero project
right-arrow Created with Sketch.
AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
FHE Frontier Energy achieves key milestone for Waroona energy project
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
NEWS From the Floor: Perth conference highlights
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.7¢ 		Change
0.002(2.35%) 		Mkt cap ! $78.43M
Open High Low Value Volume
8.6¢ 8.9¢ 8.5¢ $53.40K 614.3K

Buyers (Bids)

No. Vol. Price($)
1 49999 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 67263 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.